Mechanisms of Marburg virus gene expression05/08/2018 - 04/30/2023 (Multi-PI)
PI:
Elke Muhlberger, PhDNIH/National Institute of Allergy & Infectious Diseases5R01AI133486-03
COVID Fast Grants05/01/2020 - 02/28/2022 (PI)
Emergent Ventures at the Mercatus Center, George Mason University
Applied Research on Disinfection of Surfaces and Hands to Prevent Novel Coronavirus Transmission07/01/2020 - 06/30/2021 (Subcontract PI)
Trustees of Tufts College, Inc USAID720FDA20GR00137
Deep characterization of the biogenesis and function of Ebola virus microRNAs07/01/2019 - 06/30/2021 (Multi-PI)
PI:
Elke Muhlberger, PhDNIH/National Institute of Allergy & Infectious Diseases5R21AI147285-02
National Emerging Infectious Diseases Laboratories Operations06/01/2016 - 05/31/2021 (PI of Sub-Project / SP)
PI:
Ronald B. Corley, Ph.D.NIH/National Institute of Allergy & Infectious Diseases5UC7AI095321-07
SARS-CoV-2 infection platforms and development of virological tools to combat the COVID-19 pandemic05/01/2020 - 04/30/2021 (Subcontract PI)
President & Fellows of Harvard College on behalf of Harvard Medical School China Evergrande Gr
The role of TLR4 signaling in the pathogenesis of filovirus infection05/10/2018 - 04/30/2021 (PI)
NIH/National Institute of Allergy & Infectious Diseases5R21AI135912-02
Deciphering the pathogenic potential of Lloviu virus, a novel filovirus02/13/2018 - 01/31/2021 (PI)
NIH/National Institute of Allergy & Infectious Diseases5R21AI137793-02
Antiviral responses in iPSC-derived human primary cells to Ebola virus infection06/30/2016 - 05/31/2019 (Multi-PI)
PI:
Elke Muhlberger, PhDNIH/National Institute of Allergy & Infectious Diseases5R21AI126457-02
Deep Characterization of Rousettus Aegyptiacus Immune System: Use of bats/nonhuman primates to compare immune responses during asymtomatic/symptomatic filovirus infections01/15/2014 - 06/13/2018 (Subcontract PI)
The Geneva Foundation DOD DTRA
Showing 10 of 16 results.
Show All Results
Point-of-Care Nanotechnology Diagnostic for Differential Fever Diagnosis10/01/2015 - 10/31/2017 (SP Co-PI of Sub-Project / SP)
Becton, Dickinson and Company Paul G. Allen Fdn
SPR: Novel SPR Barrier Technology (the "USAID Agreement")11/01/2015 - 10/31/2016 (Subcontract PI)
SPR Advanced Technologies Inc. USAID
Filovirus replication: initiation mechanism and role of RNA secondary structures08/05/2014 - 07/31/2016 (PI)
NIH/National Institute of Allergy & Infectious Diseases5R03AI114293-02
Early Host Immune Response in Protection Against Filovirus Infection06/15/2009 - 05/31/2015 (PI)
NIH/National Institute of Allergy & Infectious Diseases5U01AI082954-05
IMVC Pilot Project: Mechanisms of Ebola Virus-induced Vascular Dysfunction05/01/2013 - 04/30/2015 (Subcontract PI)
Augusta University NIH NIAID5U01AI083005-05
The Antiviral Function of the Interferon-Simulated Gene IFIT105/01/2012 - 04/30/2014 (Subcontract PI)
The Washington University NIH NIAID5U01AI083005-04